Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astera Labs (ALAB) EBT (2023 - 2025)

Astera Labs has reported EBT over the past 3 years, most recently at $78.9 million for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 637.39% year-over-year to $78.9 million, compared with a TTM value of $218.2 million through Dec 2025, up 366.76%, and an annual FY2025 reading of $218.2 million, up 366.76% over the prior year.
  • EBT came in at $78.9 million for Q4 2025, up from $66.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $78.9 million in Q4 2025 to a low of -$80.4 million in Q1 2024.
  • Median EBT over the past 3 years was $6.4 million (2023), compared with a mean of $9.5 million.
  • The sharpest move saw EBT tumbled 363.98% in 2024, then soared 3216.57% in 2025.
  • Over 3 years, EBT stood at $10.7 million in 2023, then rose by 0.07% to $10.7 million in 2024, then surged by 637.39% to $78.9 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBT are $78.9 million (Q4 2025), $66.9 million (Q3 2025), and $50.7 million (Q2 2025).